Filter
1056
Filtered Results: 1056
Text search:
Anti-Tuberculosis
medicines
Featured
Recommendations
138
New Publications
379
Language
Document type
No document type
701
Guidelines
128
Studies & Reports
114
Manuals
52
Strategic & Response Plan
24
Fact sheets
12
Training Material
11
Situation Updates
10
Infographics
3
Resource Platforms
1
Countries / Regions
India
66
Kenya
38
Uganda
33
Western and Central Europe
31
Ethiopia
27
Global
25
Ghana
24
Zambia
24
Tanzania
23
South Africa
23
Liberia
21
Nigeria
21
Eastern Europe
21
Nepal
19
Myanmar / Burma
18
Malawi
17
Namibia
17
Philippines
13
Rwanda
13
Bangladesh
13
Sierra Leone
12
Ukraine
11
Asia
11
Africa
11
Zimbabwe
10
Cambodia
10
Latin America and the Carribbean
10
Lesotho
9
Russia
9
Botswana
7
South–East Asia Region
7
Venezuela
7
Pakistan
5
Mozambique
5
Eswatini/ Swaziland
5
Syria
4
Colombia
4
East and Southern Africa
4
Senegal
3
Cameroon
3
Afghanistan
3
Thailand
3
Indonesia
3
Vietnam
3
Haiti
2
Somalia
2
Jordan
2
Lebanon
2
Bolivia
2
Libya
2
Yemen
2
Eastern Europe and Central Asia
2
Poland
2
Albania
2
Tajikistan
2
Moldova
2
Turkmenistan
2
Burkina Faso
1
Congo, Democratic Republic of
1
Mali
1
Saudi Arabia
1
Iraq
1
Germany
1
Egypt
1
Gambia
1
Papua New Guinea
1
Sudan
1
Benin
1
Argentina
1
Peru
1
Brazil
1
North Macedonia
1
Hungary
1
Sri Lanka
1
Chile
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Palestine
1
Djibouti
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Qatar
1
Iran
1
Georgia
1
North America
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
482
Clinical Guidelines
123
Public Health
55
Women & Child Health
34
Pharmacy & Technologies
15
Key Resources
14
Capacity Building
10
Toolboxes
TB
230
HIV
107
AMR
61
Pharmacy
60
COVID-19
25
Mental Health
23
NCDs
19
Caregiver
18
Global Health Education
15
NTDs
14
Refugee
12
Conflict
11
Polio
9
Rapid Response
6
Planetary Health
6
Disability
5
Ebola
5
Health Financing Toolbox
5
Specific Hazards
2
Natural Hazards
1
Health Financing
1
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on ..., Module 4: Treatment - Drug-Resistant Tuberculosis Treatment provides practical guidance on how to put in place the recommendations at the scale needed to achieve national and global impact.
The document provides information on different aspects of care and support for TB patients. In particular, the handbook provides practical guidance on the implementation of the interventions that enable treatment adherence such as social support, treatment administration options, digital adherence technologies. The practical guidance also includes models of care for all TB patients, models of care for children and adolescents, integrated care for TB, HIV and comorbidities, engagement of private sector, managing of TB in health emergencies. This new practical handbook also includes two important chapters on health education and counselling, and palliative care for patients with TB.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chin...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of sympto...
Technology landscape
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
The Abuja declaration identifies that the prevention and control of HIV/AIDS, tuberculosis and related infectious diseases must come with additional financial resources. Therefore, African governments agreed on setting the target of allocating at l...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the rol...
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several ...
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention an...
2nd edition
Therapeutics Information and Pharmacovigilance Centre | TIPC
Working Document, September 2017
treat TB
Description of Research Outputs, 2009 - 2014
